FDA Inspection 988104 — Eurofins BioPharma Product Testing Czech Republic S.R.O.
The FDA completed an inspection of Eurofins BioPharma Product Testing Czech Republic S.R.O. on Aug 9, 2016 in Brno-Jih. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 9, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Brno-Jih (Czech Republic)